EUDA Health Holdings Limited (EUDA) vs Nephros, Inc. (NEPH)
A side-by-side comparison of EUDA Health Holdings Limited and Nephros, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EUDA
EUDA Health Holdings Limited
$19.11HealthcareDelayed quote: Oct 6, 2026, 2:18 PM EDT
NEPH
Nephros, Inc.
$3.49HealthcareDelayed quote: Oct 6, 2026, 2:08 PM EDT
Total return — EUDA vs NEPH
growth of $100 · dividends reinvested · last 5yEUDA -91.0% (-38.3%/yr)NEPH -49.4% (-12.7%/yr)NEPH compounded faster over this window
Log scale — wide-divergence pair
EUDA NEPH
EUDA vs NEPH: by the numbers
- •NEPH is the larger company ($38M vs $36M market cap).
- •NEPH is profitable (8.38% net margin) while EUDA runs a net loss (-40.49%).
- •NEPH grew revenue faster over the past five years (16.99% vs -5.13% CAGR).
Metrics side by side
Valuation
| Metric | EUDA | NEPH |
|---|---|---|
| P/E ratio | N/A | 21.99 |
| Forward P/E | 11.94 | 22.28 |
| P/S ratio | 3.03 | 1.83 |
| P/B ratio | N/A | 3.17 |
| EV / EBITDA | N/A | 19.30 |
Profitability
| Metric | EUDA | NEPH |
|---|---|---|
| Gross margin | 41.73% | 60.31% |
| Operating margin | -36.42% | 7.92% |
| Net margin | -40.49% | 8.38% |
| ROE | N/A | 14.51% |
| ROIC | N/A | 12.67% |
Growth (annualized)
| Metric | EUDA | NEPH |
|---|---|---|
| Revenue CAGR (5Y) | -5.13% | 16.99% |
| Total return CAGR (5Y) | N/A | -15.93% |
Frequently asked
- Which has grown faster, EUDA or NEPH?
- Over the past five years, NEPH grew revenue faster — EUDA at a -5.13% CAGR versus NEPH at 16.99%.
- Is EUDA or NEPH more profitable?
- NEPH runs the higher net margin — EUDA at -40.49% versus NEPH at 8.38%.
Go deeper
Dig into the metrics
Nephros P/E ratioEUDA Health ROENephros ROEEUDA Health operating marginNephros operating marginEUDA Health revenue growthNephros revenue growthEUDA Health free cash flowNephros free cash flow
EUDA Health & Nephros appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.